Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22559 | 377 | 27.4 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
236 | 3 | ADENOSINE//NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS//ADENOSINE RECEPTORS | 48331 |
2341 | 2 | RIBONUCLEOTIDE REDUCTASE//POLG//HYDROXYUREA | 4410 |
22559 | 1 | HYDROXYUREA//GENET HUMAN THER Y//AV HALTS | 377 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HYDROXYUREA | authKW | 1517867 | 38% | 13% | 143 |
2 | GENET HUMAN THER Y | address | 385908 | 2% | 53% | 9 |
3 | AV HALTS | authKW | 161990 | 1% | 100% | 2 |
4 | BISTHIOSEMICARBAZONATE GOLDIII COMPLEXES | authKW | 161990 | 1% | 100% | 2 |
5 | DERMATOMYOSITIS LIKE ERUPTION | authKW | 161990 | 1% | 100% | 2 |
6 | MACROERYTHROCYTOSIS | authKW | 161990 | 1% | 100% | 2 |
7 | VS411 | authKW | 161990 | 1% | 100% | 2 |
8 | RIGHT | address | 134985 | 1% | 33% | 5 |
9 | TARGET CELL AVAILABILITY | authKW | 107992 | 1% | 67% | 2 |
10 | VIROSTATIC | authKW | 107992 | 1% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Dermatology | 4001 | 25% | 0% | 94 |
2 | Infectious Diseases | 775 | 14% | 0% | 53 |
3 | Virology | 753 | 11% | 0% | 42 |
4 | Pharmacology & Pharmacy | 325 | 19% | 0% | 72 |
5 | Immunology | 258 | 14% | 0% | 53 |
6 | Hematology | 228 | 8% | 0% | 31 |
7 | Oncology | 126 | 11% | 0% | 43 |
8 | Medicine, General & Internal | 71 | 8% | 0% | 30 |
9 | Microbiology | 16 | 4% | 0% | 16 |
10 | Crystallography | 15 | 2% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GENET HUMAN THER Y | 385908 | 2% | 53% | 9 |
2 | RIGHT | 134985 | 1% | 33% | 5 |
3 | DIPARTMENTO BIOTECNOL CALLULARI EMATOL | 80995 | 0% | 100% | 1 |
4 | DISEM ENDOCRINOL METAB SCI | 80995 | 0% | 100% | 1 |
5 | HAEMATOL ANGIOL | 80995 | 0% | 100% | 1 |
6 | IST SCI MEDSERV EMATOLSERV EMATOL DIAGNOST | 80995 | 0% | 100% | 1 |
7 | OOERODEK DIAGNOSTYKI THER II AIDS | 80995 | 0% | 100% | 1 |
8 | PHARMEPPLEY CANC CORE PHARMACOKINET | 80995 | 0% | 100% | 1 |
9 | RAMBAM MED MED PATHOL | 80995 | 0% | 100% | 1 |
10 | SCOTT SHERWOOD BRINDLEY FDNSCOTT WHITE CLIN | 80995 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 1818 | 3% | 0% | 11 |
2 | ANTIVIRAL THERAPY | 1547 | 2% | 0% | 6 |
3 | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1476 | 4% | 0% | 15 |
4 | ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 1411 | 3% | 0% | 10 |
5 | FUNDAMENTAL AND CLINICAL IMMUNOLOGY | 1371 | 0% | 2% | 1 |
6 | AIDS | 1338 | 3% | 0% | 12 |
7 | CLINICAL AND EXPERIMENTAL DERMATOLOGY | 1311 | 2% | 0% | 9 |
8 | EUROPEAN JOURNAL OF DERMATOLOGY | 1091 | 2% | 0% | 6 |
9 | JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS | 979 | 1% | 0% | 4 |
10 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 881 | 2% | 0% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HYDROXYUREA | 1517867 | 38% | 13% | 143 | Search HYDROXYUREA | Search HYDROXYUREA |
2 | AV HALTS | 161990 | 1% | 100% | 2 | Search AV+HALTS | Search AV+HALTS |
3 | BISTHIOSEMICARBAZONATE GOLDIII COMPLEXES | 161990 | 1% | 100% | 2 | Search BISTHIOSEMICARBAZONATE+GOLDIII+COMPLEXES | Search BISTHIOSEMICARBAZONATE+GOLDIII+COMPLEXES |
4 | DERMATOMYOSITIS LIKE ERUPTION | 161990 | 1% | 100% | 2 | Search DERMATOMYOSITIS+LIKE+ERUPTION | Search DERMATOMYOSITIS+LIKE+ERUPTION |
5 | MACROERYTHROCYTOSIS | 161990 | 1% | 100% | 2 | Search MACROERYTHROCYTOSIS | Search MACROERYTHROCYTOSIS |
6 | VS411 | 161990 | 1% | 100% | 2 | Search VS411 | Search VS411 |
7 | TARGET CELL AVAILABILITY | 107992 | 1% | 67% | 2 | Search TARGET+CELL+AVAILABILITY | Search TARGET+CELL+AVAILABILITY |
8 | VIROSTATIC | 107992 | 1% | 67% | 2 | Search VIROSTATIC | Search VIROSTATIC |
9 | ADRENAL GLANDS RAT | 80995 | 0% | 100% | 1 | Search ADRENAL+GLANDS+RAT | Search ADRENAL+GLANDS+RAT |
10 | ADRENALECTOMY RAT | 80995 | 0% | 100% | 1 | Search ADRENALECTOMY+RAT | Search ADRENALECTOMY+RAT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | QUATTRONE, F , DINI, V , BARBANERA, S , ZERBINATI, N , ROMANELLI, M , (2013) CUTANEOUS ULCERS ASSOCIATED WITH HYDROXYUREA THERAPY.JOURNAL OF TISSUE VIABILITY. VOL. 22. ISSUE 4. P. 112-121 | 38 | 76% | 5 |
2 | UGLIETTI, A , MASERATI, R , (2011) ANTIVIRAL HYPERACTIVATION-LIMITING THERAPEUTICS AS A NOVEL CLASS FOR THE TREATMENT OF HIV/AIDS: FOCUS ON VS411.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 20. ISSUE 4. P. 559 -565 | 26 | 60% | 1 |
3 | SANCHEZ-PALACIOS, C , GUITART, J , (2004) HYDROXYUREA-ASSOCIATED SQUAMOUS DYSPLASIA.JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. VOL. 51. ISSUE 2. P. 293-300 | 27 | 66% | 21 |
4 | FRIEDRICH, S , RAFF, K , LANDTHALER, M , KARRER, S , (2004) CUTANEOUS ULCERATIONS ON HANDS AND HEELS SECONDARY TO LONG-TERM HYDROXYUREA TREATMENT.EUROPEAN JOURNAL OF DERMATOLOGY. VOL. 14. ISSUE 5. P. 343-346 | 19 | 90% | 7 |
5 | DE FORNI, D , STEVENS, MR , LORI, F , (2010) STRATEGIES TO IMPROVE EFFICACY AND SAFETY OF A NOVEL CLASS OF ANTIVIRAL HYPER-ACTIVATION-LIMITING THERAPEUTIC AGENTS: THE VS411 MODEL HIV/AIDS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 161. ISSUE 4. P. 830 -843 | 25 | 52% | 3 |
6 | BONEBERGER, S , RUPEC, RA , RUZICKA, T , (2010) ULCERS FOLLOWING THERAPY WITH HYDROXYUREA - THREE CASE REPORTS AND REVIEW OF THE LITERATURE.HAUTARZT. VOL. 61. ISSUE 7. P. 598-602 | 15 | 83% | 1 |
7 | KALAJIAN, AH , CELY, SJ , MALONE, JC , BURRUSS, JB , CALLEN, JP , (2010) HYDROXYUREA-ASSOCIATED DERMATOMYOSITIS-LIKE ERUPTION DEMONSTRATING ABNORMAL EPIDERMAL P53 EXPRESSION A POTENTIAL PREMALIGNANT MANIFESTATION OF CHRONIC HYDROXYUREA AND UV RADIATION EXPOSURE.ARCHIVES OF DERMATOLOGY. VOL. 146. ISSUE 3. P. 305 -310 | 15 | 71% | 11 |
8 | SALMON-EHR, V , LEBORGNE, G , VILQUE, JP , POTRON, G , BERNARD, P , (2000) HYDROXYUREA CUTANEOUS SIDE-EFFECTS: PROSPECTIVE STUDY OF 26 PATIENTS FROM A DERMATOLOGICAL CONSULTATION..REVUE DE MEDECINE INTERNE. VOL. 21. ISSUE 1. P. 30-34 | 15 | 94% | 15 |
9 | MAYHEW, CN , PHILLIPS, JD , GREENBERG, RN , BIRCH, NJ , ELFORD, HL , GALLICCHIO, VS , (1999) IN VIVO AND IN VITRO COMPARISON OF THE SHORT-TERM HEMATOPOIETIC TOXICITY BETWEEN HYDROXYUREA AND TRIMIDOX OR DIDOX, NOVEL RIBONUCLEOTIDE REDUCTASE INHIBITORS WITH POTENTIAL ANTI-HIV-1 ACTIVITY.STEM CELLS. VOL. 17. ISSUE 6. P. 345 -356 | 24 | 56% | 21 |
10 | SCHWONZEN, M , SPANGENBERGER, H , SPENGLER, M , (2003) HYDROXYUREA-INDUCED PNEUMONITIS.MEDIZINISCHE KLINIK. VOL. 98. ISSUE 7. P. 394-397 | 13 | 93% | 4 |
Classes with closest relation at Level 1 |